PubMed · 1990 · 172 citations · 29 references
Life SciencesOncologyUrologyCytogeneticsGenitourinary OncologyNeoplasiaAneuploidyCancer CytogeneticsChromosome AberrationsMalignant NeoplasmsProstate CancerStructural Chromosome AbnormalitiesChromosome Structural AberrationsCytogenetic AbnormalitiesDouble Minute ChromosomesKaryotypic AbnormalitiesProstate AdenocarcinomaStructural Chromosomal AberrationsStructural Chromosome AberrationsStructural Chromosome Rearrangements
The cytogenetic evaluation of 30 cultured primary prostatic cancer specimens obtained during radical prostatectomies of patients with relatively early stage disease is reported. The majority of specimens examined showed a normal male karyotype, 46,XY. Nine samples contained clonally abnormal populations including five specimens which were hyperdiploid (modal range, 65-92 chromosomes), one specimen containing double minute chromosomes, and three containing structural aberrations. Loss of the Y chromosome and a partial trisomy for chromosome 4 was observed in a sample from one patient. Another sample showed a translocation between the long arms of chromosomes 5 and 7. The only tumor obtained from a previously irradiated patient contained no normal cells, a modal chromosome number of 45, loss of chromosomes 2 and Y, and multiple structural rearrangements. The appearance of any clonal cytogenetic abnormality correlated in general with a poorly differentiated state of cancer. A survey of all available previous cytogenetic data on human prostate adenocarcinoma indicated that the loss of chromosomes 1, 2, 5, and Y, the gain of chromosomes 7, 14, 20, and 22, and rearrangements involving chromosome arms 2p, 7q, and 10q are the most common changes observed. This suggests that, although the assignment of a single chromosomal aberration as a marker for early stage prostatic cancer is unlikely, several consistent "hotspots" might be of significance in the etiology of this disease.
29
Prostate-Specific Antigen as a Serum Marker for Adenocarcinoma of the Prostate
Thomas A. Stamey, Norman Yang, Alan R. Hay et al. · New England Journal of Medicine · 1987 · 2.5K citations
Isolation of a human prostate carcinoma cell line (DU 145)
Kenneth R. Stone, Don D. Mickey, Heidi Wunderli et al. · International Journal of Cancer · 1978 · 1.2K citations
Zonal Distribution of Prostatic Adenocarcinoma
John E. McNeal, Elise A. Redwine, Fuad S. Freiha et al. · The American Journal of Surgical Pathology · 1988 · 1.2K citations
PATTERNS OF PROGRESSION IN PROSTATE CANCER
JohnE. Mcneal, RobertA. Kindrachuk, FuadS. Freiha et al. · The Lancet · 1986 · 587 citations
Morphometric and Clinical Studies on 68 Consecutive Radical Prostatectomies
Thomas A. Stamey, John E. McNeal, Fuad S. Freiha et al. · The Journal of Urology · 1988 · 438 citations